Home > Insider Trading > Filing (0000884731-16-000019)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494892	Frank Haluska	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139	Svp, Clinical R&D, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-19	6,500	$0.00	150,586	No	4	M	Direct
Common Stock	Disposition	2016-03-21	3,575	$6.47	147,011	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2016-03-19	6,500	$0.00	6,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Shares were acquired upon the vesting of a Restricted Stock Unit dated 03/19/2013
Represents shares sold to satisfy withholding tax requirements pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a right to receive one share of ARIAD common stock.
Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016